Overview

Evaluating the Efficacy and Safety of Vardenafil in Patients Erectile Dysfunction Solely Secondary to Spinal Cord Injury

Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
Investigate efficacy and safety of Vardenafil in patients with spinal cord injury
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Collaborator:
GlaxoSmithKline
Treatments:
Vardenafil Dihydrochloride